Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
304.49
-11.43 (-3.62%)
At close: Dec 5, 2025, 4:00 PM EST
304.20
-0.29 (-0.10%)
After-hours: Dec 5, 2025, 7:49 PM EST
Insulet Revenue
Insulet had revenue of $706.30M in the quarter ending September 30, 2025, with 29.86% growth. This brings the company's revenue in the last twelve months to $2.52B, up 27.11% year-over-year. In the year 2024, Insulet had annual revenue of $2.07B with 22.07% growth.
Revenue (ttm)
$2.52B
Revenue Growth
+27.11%
P/S Ratio
8.49
Revenue / Employee
$646,615
Employees
3,900
Market Cap
21.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
| Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
| Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
| Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
| Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PODD News
- 2 days ago - Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Business Wire
- 10 days ago - Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off - Seeking Alpha
- 16 days ago - Insulet Corporation (PODD) Analyst/Investor Day Transcript - Seeking Alpha
- 16 days ago - Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day - Business Wire
- 24 days ago - PODD Vs. Intuitive Surgical: This Underdog Might Just Win - Forbes
- 4 weeks ago - Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Insulet tops quarterly estimates on demand for wearable insulin pumps - Reuters
- 4 weeks ago - Insulet Reports Third Quarter 2025 Results - Business Wire